🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Ten things I wish I had known about academic primary care – BJGP Life bjgplife.com/ten-things-i-w…

Our latest research The British Journal of General Practice: Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI. Led by Constantinos Koshiaris James Sheppard Richard McManus. bjgp.org/content/early/…

Using nationally representative electronic health record data, James Peter Sheppard and team investigate the association between antihypertensives and serious adverse events in individuals aged 40+ in England. doi.org/10.1371/journa… James Sheppard Richard McManus #OpenAccess

Fascinating analysis of SPRINT demonstrating age bias w/ hypertension management. Age was independently associated with therapeutic inertia! Evidence for Age Bias Contributing to Therapeutic Inertia in BP Management: A Secondary Analysis of SPRINT ahajournals.org/doi/abs/10.116…

This study developed a clinical prediction model which accurately identifies patients at high risk of acute kidney injury doi.org/10.3399/BJGP.2… Richard Riley (R²) Richard Stevens Prof Amitava Banerjee💙 Andrew Clegg Juliet Usher-Smith Richard McManus lucinda.archer Watch the <1-minute clip

Listen to Dr James Sheppard describe an acute kidney injury risk prediction tool which could reassure most patients on antihypertensives of low AKI risk. bjgplife.com/119 Richard Riley (R²) Richard Stevens Prof Amitava Banerjee💙 Andrew Clegg Juliet Usher-Smith #PrimaryCare

Our new paper in PLOS Medicine assessing treatment efficacy in people with multiple long-term conditions included in drug trials. A difficult question as people with multiple conditions are under-represented in clinical trials. We found no difference in efficacy by comorbidity

Calling all health data geeks! Looking for a post-doc to work with the University of Exeter Faculty of Health & Life Sci team in ageing and cardiovascular health. Working with @CPRD and UK Biobank Flexibility on % and hybrid working. tinyurl.com/5d57v74e Health Data Research UK (HDR UK) Ageing Data Research Collaborative James Sheppard exeterageing APEx (also on Blue Sky)

The OPTIMISE 2 trial will further assess the safety of deprescribing blood pressure drugs, recruiting patients aged 75+ on antihypertensives without raised BP readings. If you're a GP in England and interested in taking part in this new trial, visit: phc.ox.ac.uk/research/insti…

A great opportunity to come and work with a wonderful team!